Article Text

Download PDFPDF
CASE REPORT
Malignant hypertension as a rare cause of thrombotic microangiopathy
  1. Guramrinder Thind,
  2. Karthik Kailasam
  1. Internal Medicine, Western Michigan University School of Medicine, Kalamazoo, Michigan, USA
  1. Correspondence to Dr Guramrinder Thind, guramrinder.thind{at}med.wmich.edu

Summary

Malignant hypertension can occasionally be associated with microangiopathic haemolytic anaemia. A 38-year-old male presented with nausea, vomiting, loss of appetite and oliguria for 2 weeks. He was diagnosed with hypertensive emergency with cardiac and renal dysfunction. Interestingly, further workup was diagnostic for the presence of thrombotic microangiopathy (TMA): haemoglobin =12.7 g/dL, indirect bilirubin =2.0 mg/dL, haptoglobin ≤6 mg/dL, platelet count =121 000/μL and schistocytes on peripheral smear. At the outset, the cause of TMA was unclear. Patient denied having diarrhoea, making haemolytic uremic syndrome less likely. A normal ADAMTS13 activity test ruled out thrombotic thrombocytopaenic purpura. Malignant hypertension induced TMA was highest on the differential and plasma exchange was deferred. Renal biopsy revealed features of TMA and malignant nephrosclerosis. Patient eventually became dialysis dependent. Aggressive blood pressure control was obtained with multiple medications.

  • Hypertension
  • Acute renal failure

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Both authors contributed to the manuscript as follows. GT was part of the primary team who admitted the patient and KK was on the nephrology team, which was consulted for the patient at that time. Hence, both authors were directly involved with patient care. GT did the literature review and manuscript write-up. KK revised the manuscript critically for important intellectual content. Both authors gave their final approval of the version to be published.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.